LifePoint Health, Inc. (NASDAQ:LPNT) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday.

According to Zacks, “LifePoint Health’s stock has underperformed the industry in the last six months. Following second-quarter results, the company trimmed its 2017 guidance on a challenging volume environment and weak revenue growth. The company is faced with increasing expenses which has outpaced revenue growth thereby squeezing operating margins. High bad debt is another concern. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2.9% downward over the last 30 days.”

A number of other analysts have also recently commented on the company. TheStreet cut LifePoint Health from a “b-” rating to a “c+” rating in a research report on Wednesday, August 16th. ValuEngine upgraded LifePoint Health from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. BidaskClub cut LifePoint Health from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Royal Bank Of Canada reiterated a “buy” rating and set a $77.00 price objective on shares of LifePoint Health in a research report on Wednesday, July 5th. Finally, Leerink Swann upgraded LifePoint Health from a “market perform” rating to an “outperform” rating and upped their price objective for the company from $73.00 to $74.00 in a research report on Tuesday, June 6th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $66.18.

LifePoint Health (LPNT) opened at 56.00 on Tuesday. The company has a market capitalization of $2.25 billion, a PE ratio of 12.54 and a beta of 0.86. The firm’s 50-day moving average is $60.77 and its 200-day moving average is $62.61. LifePoint Health has a 52-week low of $50.60 and a 52-week high of $70.95.

LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.06. The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.64 billion. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. LifePoint Health’s revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.69 earnings per share. On average, equities research analysts forecast that LifePoint Health will post $4.07 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Zacks Investment Research Downgrades LifePoint Health, Inc. (LPNT) to Sell” was originally published by American Banking News and is owned by of American Banking News. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://www.americanbankingnews.com/2017/08/29/zacks-investment-research-downgrades-lifepoint-health-inc-lpnt-to-sell.html.

In related news, Chairman William F. Carpenter III sold 82,347 shares of the stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the completion of the transaction, the chairman now directly owns 504,535 shares of the company’s stock, valued at $32,365,920.25. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Chairman William F. Carpenter III sold 17,653 shares of the stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $65.06, for a total value of $1,148,504.18. Following the transaction, the chairman now directly owns 439,841 shares of the company’s stock, valued at $28,616,055.46. The disclosure for this sale can be found here. Company insiders own 7.28% of the company’s stock.

A number of institutional investors have recently made changes to their positions in the stock. Victory Capital Management Inc. raised its position in shares of LifePoint Health by 65.2% in the third quarter. Victory Capital Management Inc. now owns 1,692 shares of the company’s stock worth $100,000 after buying an additional 668 shares during the last quarter. Fuller & Thaler Asset Management Inc. bought a new stake in LifePoint Health during the second quarter valued at about $111,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in LifePoint Health by 10.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after buying an additional 164 shares during the last quarter. LS Investment Advisors LLC raised its stake in LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock valued at $120,000 after buying an additional 543 shares during the last quarter. Finally, Acrospire Investment Management LLC bought a new stake in LifePoint Health during the first quarter valued at about $125,000. 99.53% of the stock is owned by institutional investors.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Get a free copy of the Zacks research report on LifePoint Health (LPNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.